Method for using texturing surfaces of optical fiber sensors for blood glucose monitoring -> Monitor Keywords
Fresh Patents
Monitor Patents Patent Organizer File a Provisional Patent Browse Inventors Browse Industry Browse Agents Browse Locations
site info Site News  |  monitor Monitor Keywords  |  monitor archive Monitor Archive  |  organizer Organizer  |  account info Account Info  |  
09/21/06 - USPTO Class 436 |  63 views | #20060211126 | Prev - Next | About this Page  436 rss/xml feed  monitor keywords

Method for using texturing surfaces of optical fiber sensors for blood glucose monitoring

USPTO Application #: 20060211126
Title: Method for using texturing surfaces of optical fiber sensors for blood glucose monitoring
Abstract: Disclosed is a method and the resulting product thereof comprising a solid light-conducting fiber with a point of attachment and having a textured surface site consisting a textured distal end prepared by being placed in a vacuum and then subjected to directed hyperthermal beams comprising oxygen ions or atoms. The textured distal end comprises cones or pillars that are spaced upon from each other by less than 1 micron and are extremely suitable to prevent cellular components of blood from entering the valleys between the cones or pillars so as to effectively separate the cellular components in the blood from interfering with optical sensing of the glucose concentration for diabetic patients. (end of abstract)



Agent: John P. Mcmahon - Hudson, OH, US
Inventor: Bruce A. Banks
USPTO Applicaton #: 20060211126 - Class: 436164000 (USPTO)

Related Patent Categories: Chemistry: Analytical And Immunological Testing, Optical Result

Method for using texturing surfaces of optical fiber sensors for blood glucose monitoring description/claims


The Patent Description & Claims data below is from USPTO Patent Application 20060211126, Method for using texturing surfaces of optical fiber sensors for blood glucose monitoring.

Brief Patent Description - Full Patent Description - Patent Application Claims
  monitor keywords



CROSS REFERENCE TO RELATED APPLICATIONS

[0001] This application is a divisional application of co-pending parent case Ser. No. 10/942,637, which was filed on Sep. 16, 2004.

ORIGIN OF THE INVENTION

[0002] The invention described herein was made by an employee of the United States Government and may be used by or for the Government for governmental purposes without payment of any royalties thereon or therefor.

FIELD OF THE INVENTION

[0003] The present invention relates to a sensing device for determination of compounds in fluids, and more particularly, to a solid light-conducting fiber comprising the sensing device with a point of attachment and having a textured surface consisting of a distal end prepared by being placed in a vacuum system and then subjected to directed hyperthermal beams comprising oxygen ions or atoms.

BACKGROUND OF THE INVENTION

[0004] The quantification of chemical and biochemical components in aqueous fluids, and particularly in biological fluids such as whole blood or urine and in biological fluid derivatives such as serum and plasma, is of ever increasing importance. Important applications exist in medical diagnosis and treatment and in the quantification of exposure to therapeutic drugs, intoxicants, hazardous chemicals and the like. These applications include the detection and quantification of an increasing variety of certain circulating antibodies, cancer-related metabolites, genetically derived chemical tracers, and hormones emitted during events such as pregnancy. In many instances, the amounts of materials being determined are minuscule in the range of a microgram or less per deciliter.

[0005] One common medical test is the measurement of blood glucose levels by diabetics which is more fully described in U.S. Pat. No. 5,859,937 ('937) of H. Nomura and herein incorporated by reference. Portions of the teachings of the '937 patent are used herein for the sake of completeness. The glucose determination, as described in the '937 patent, typically entails the diabetic piercing the skin of his or her finger with a lance, followed by squeezing or expression of a blood droplet. The blood droplet is then transferred to a reagent pad or test strip. The amount of blood that is conveniently expressed from a finger prick is governed by the size and depth of penetration of the lance. Too small a nick results in an inadequately sized blood sample for the intended analysis. Conversely, too deep a nick results in an oversized blood sample. Pain is experienced in the lancing procedure, and the degree of pain is associated with the size and depth of penetration of the lance.

[0006] The teachings of the '937 patent provides a textured site allowing for an increased surface area, compared to other prior art devices, for use in blood sampling. The increased surface area provides an advantage relating to minimizing the invasive feature of glucose testing because the surface area being very small, greatly reduces the level of analyte-responsive needed to be deposited to perform the glucose determination. Increased surface area allows one to utilize a small blood droplet, for instance, a droplet having a volume of one (1) to five (5) microliters, or preferably 1 to 2.5 microliters. The '937 patent allows for a reduction relative to the prior art thereof, of about one-fifth to about one-tenth of the fluid volume necessary blood glucose sensing. It is desired that further improvements to the surface area be provided, so as to correspondingly reduce the amount of blood necessary for determination of glucose for diabetics.

[0007] The '937 patent provides a textured surface using various means, such as ion beam sputtering, plasma etching including atomic oxygen plasma, physical abrasion, chemical etching, sputtering or ablation by high energy beams, or deposition of dendritic-like structures thereon. The textured surface of the '937 patent is intended to provide a means for separating cellular components in blood from the plasma of the blood so as to allow optical sensing of the glucose concentration in the blood. The processes described in the '937 patent for developing the textured surface need to produce a cone or pillar structure at the ends of optical fibers or other sensing surfaces which are sufficiently close--so as to prevent the cellular components from entering the microscopic valleys between the cones or pillars so that optical sensing of the glucose concentration can be performed. Also, it is desired to have a sufficiently high aspect ratio (height to width) of cones or pillars to allow sufficient surface area for optical determination of the glucose concentration in the blood.

[0008] In pursuit for finding desired pillar structures for the textured surfaces, some of the different processes mentioned in the '937 patent were investigated and may be further described with reference to FIG. 1 herein, which illustrates a Scanning Electron Microscope image of the end of a polymethylmethacrylate optical fiber that was textured by the use of thermal energy (<0.5 eV) atomic oxygen through salt dust for enhancing texturing.

[0009] The disadvantages of prior art results shown in FIG. 1 is that the craters produced were too wide to prevent cellular blood components from entering the optical sensing areas and the aspect ratio (height to width) of the surface features does not offer high gains in surface area relative to flat surfaces. As can be seen in FIG. 1, the cone or crater ridges are approximately 20-30 microns apart far too much to achieve their desired goals. More particularly, the spacing between cones or ridges needs to be .ltoreq.5 microns to block the entry of blood cells into the cone valleys. Thus, the craters did not provide separation of the plasma from the blood in the areas of the valleys between the cones or pillars where optical sensing of the glucose concentration needs to occur. Use of thermal energy (<0.5 eV) atomic oxygen, sometimes referred to as isotropic thermal energy, to texture the surfaces of clear polymers such as polymethylmethacrylate, polystyrene or other hydrocarbon polymer (even with the use of small particle salt shielding) causes wide almost hemispherical craters to form surface features which are only as high as they are wide. The aspect ratio of only approximately one (1) requires greater volume blood samples than desirable. It is desired that textured surfaces for optical sensors used for blood testing be provided that provide cones or pillars that are spaced apart from each other by less than 5 microns, preferably about 1 micron, and having an aspect ratio (height to width) of greater than one (1).

OBJECTS OF THE INVENTION

[0010] It is a primary object of the present invention to provide a process that creates a sensor having a textured surface comprising cones or pillars that are spaced apart from each other by less than 5 microns, preferably about 1 micron, and having an aspect ratio of greater than one (1).

[0011] Moreover, it is an object of the present invention to provide a process for making fine texture, high aspect ratio cone surface at the distal end of a solid light-conducting fiber that is necessary for optical fiber blood glucose monitoring with small blood samples.

[0012] It is a further object of the present invention to provide for an optical sensor having cones or pillars that are sufficiently close so as to prevent cellular blood components for interfering with optical sensing of the blood glucose concentration.

[0013] Still further, it is an object of the present invention to provide a process that creates a textured surface for an optical sensing device which has a high surface area that correspondingly allows for a reduction in the amount of blood needed to be removed from a patient so as to reduce the pain to which the patient needs to be subjected for glucose determination.

[0014] It is a further object of the present invention to provide for optical polymer devices serving the sensors that may be used for blood plasma diagnostics that require economic separation of plasma in the whole blood for optical sensing measurements.

SUMMARY OF THE INVENTION

[0015] The present invention provides for a process that produces a solid light-conducting fiber with a point of attachment and having a distal end possessing a fine texture, high aspect ratio cone surface that provides for optical fiber blood glucose monitoring with small blood samples.

[0016] The textured distal end of the solid light-conducting fiber is prepared by being placed in a vacuum and then subjected to direct hyperthermal beams comprising oxygen ions or atoms.

BRIEF DESCRIPTION OF THE DRAWINGS

[0017] FIG. 1 illustrates a prior art Scanning Electron Microscope image of the end of an optical fiber that was textured by the use of thermal energy (<0.5 eV) atomic oxygen through salt dust to enhance texturing;

Continue reading about Method for using texturing surfaces of optical fiber sensors for blood glucose monitoring...
Full patent description for Method for using texturing surfaces of optical fiber sensors for blood glucose monitoring

Brief Patent Description - Full Patent Description - Patent Application Claims

Click on the above for other options relating to this Method for using texturing surfaces of optical fiber sensors for blood glucose monitoring patent application.
###
monitor keywords

How KEYWORD MONITOR works... a FREE service from FreshPatents
1. Sign up (takes 30 seconds). 2. Fill in the keywords to be monitored.
3. Each week you receive an email with patent applications related to your keywords.  
Start now! - Receive info on patent apps like Method for using texturing surfaces of optical fiber sensors for blood glucose monitoring or other areas of interest.
###


Previous Patent Application:
Electrolytic eluent generator
Next Patent Application:
Blood testing unit and blood testing method and apparatus
Industry Class:
Chemistry: analytical and immunological testing

###

FreshPatents.com Support
Thank you for viewing the Method for using texturing surfaces of optical fiber sensors for blood glucose monitoring patent info.
IP-related news and info


Results in 0.12543 seconds


Other interesting Feshpatents.com categories:
Canon USA , Celera Genomics , Cephalon, Inc. , Cingular Wireless , Clorox , Colgate-Palmolive , Corning , Cymer , 174
filepatents (1K)

* Protect your Inventions
* US Patent Office filing
patentexpress PATENT INFO